Bishops Stortford, United Kingdom

Fintan Kelleher


Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Bishops Stortford, GB (1995)
  • Harlow, GB (1997)
  • Dublin, GB (2000)

Company Filing History:


Years Active: 1995-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Fintan Kelleher

Introduction

Fintan Kelleher is a prominent inventor based in Bishops Stortford, Great Britain. He has made significant contributions to the field of therapeutic agents, holding a total of three patents. His innovative approaches in medicinal chemistry demonstrate a strong commitment to improving healthcare through advanced research.

Latest Patents

Among Fintan Kelleher's latest patents are:

1. Spiro-ketal derivatives and their use as therapeutic agents.

2. Aromatic compounds, compositions containing them, and their use in therapy.

These inventions exemplify his focus on novel therapeutic solutions that could revolutionize treatment options in various medical fields.

Career Highlights

Fintan Kelleher is currently affiliated with Merck Sharp & Dohme Corporation, where he actively contributes to groundbreaking research initiatives. His work encompasses not only the development of innovative compounds but also the practical application of these inventions in therapeutic settings.

Collaborations

Throughout his career, Fintan has notably collaborated with several talented individuals, including Richard Thomas Lewis and Jason Matthew Elliott. These partnerships have fostered an environment of creativity and innovation, facilitating the successful development of various projects.

Conclusion

In summary, Fintan Kelleher's work as an inventor is marked by his dedication to advancing medical science through innovation. With a solid portfolio of patents and fruitful collaborations, he continues to be a vital asset in the fields of medicinal chemistry and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…